New Key Statistics Module, Z-Score and F-Score
OTCPK:MITPF Key Ratios
| Market Cap $ M | 15.73 |
| Enterprise Value $ M | 216.07 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 2.40 |
| Price/Book | -- |
| Price/Sales | 0.18 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 66.00 |
| EPS (TTM) $ | -1.51 |
| Beneish M-Score | -0.95 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -14.61 |
| EV-to-EBITDA | -150.38 |
| PEG | -- |
| Shares Outstanding M | 66.91 |
| Net Margin (%) | -125.80 |
| Operating Margin % | -62.11 |
| Pre-tax Margin (%) | -54.19 |
| Quick Ratio | 0.49 |
| Current Ratio | 1.04 |
| ROA % (ttm) | -18.93 |
| ROE % (ttm) | -387.23 |
| ROIC % (ttm) | -23.96 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.00 |
MITPF Number of Guru Trades
MITPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:MITPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:MITPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Mithra Pharmaceuticals SA Insider Transactions
No Available Data
News about OTCPK:MITPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers